ArticleJournal of health economics2017
The moral hazard effects of consumer responses to targeted cost-sharing.
Article in Journal of health economics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Economic Evidence on Cost Sharing and Alternative Insurance Designs to Address Moral and Behavioral Hazards in High-Income Health Care Systems: A Systematic Review.Journal of market access & health policy · 2024Review
- If Patients Don't Use Available Health Service Pricing Information, Is Transparency Still Important?AMA journal of ethics · 2022Article
- Paying patients to use lower-priced providers.Health services research · 2022Article
- Does the Implementation of Reference Pricing Result in Reduced Utilization? Evidence From Inpatient and Outpatient Procedures.Medical care research and review : MCRR · 2022Article
- Is physician location sensitive to changes in patients' financial responsibility?Journal of applied economics · 2022Article
- Demand-side Interventions to Control Moral Hazard in Health Systems, Beneficial or Detrimental: A Systematic Review Study.Medical journal of the Islamic Republic of Iran · 2022Review
- Understanding the distributional impacts of health insurance reform: Evidence from a consumer cost-sharing program.Health economics · 2021Article
- Higher Medicare Spending On Imaging And Lab Services After Primary Care Physician Group Vertical Integration.Health affairs (Project Hope) · 2021Article
- An Employer-Provider Direct Payment Program Is Associated With Lower Episode Costs.Health affairs (Project Hope) · 2021Article
- Exploring the Factors Triggering Occupational Ethics Risk of Technology Transaction in Chinese Construction Industry.International journal of environmental research and public health · 2020Article
- Reference pricing: The case of screening colonoscopies.Journal of health economics · 2019Article
- Paying Patients To Switch: Impact Of A Rewards Program On Choice Of Providers, Prices, And Utilization.Health affairs (Project Hope) · 2019Article
- How robust are reference pricing studies on outpatient medical procedures? Three different preprocessing techniques applied to difference-in differences.Health economics · 2019Article
- Firm responses to targeted consumer incentives: Evidence from reference pricing for surgical services.Journal of health economics · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This paper examines the effects of the reference pricing program implemented by the California Public Employees Retirement System (CalPERS) in 2012. The program uses targeted cost-sharing to incentivize patient price shopping. We find that the program leads to a 10.3% increase in the use of low-price providers and reduces the average cost per procedure by 12.5%. We further estimate that the program reduces medical spending by $218.8 per procedure, which we estimate is approximately 53.7% of the excessive spending that is due to patient choice of higher price providers caused by insurance coverage, at the expense of a $94.3 (or 12.5%) reduction in consumer surplus. The cost savings from the reference pricing program is about two to three times as large as the reduction from implementing a high-deductible health plan, while the accompanying consumer surplus reduction is much smaller under reference pricing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.